Retatrutide

Retatrutide is a novel synthetic peptide engineered to act as a triple agonist at the GIP, GLP-1, and glucagon receptors. It is one of the most actively studied compounds in current metabolic research literature, with laboratory interest centered on energy expenditure, glucose homeostasis, and lipid metabolism pathways. Each vial is independently tested for identity and purity. For research use only — not for human consumption.